| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 26296-50-4 | Ficaprenol 11 | C55H90O |
| 26296-54-8 | Physcion-1-O-beta-D-Glucopyranoside | C22H22O10 |
| 26296-56-0 | Toxol | C13H14O3 |
| 26299-14-9 | Pyridinium chlorochromate | C5H5N.HCrO3Cl |
| 26299-47-8 | 2-Propenoic Acid, Butyl Ester, Polymer With Ethenylbenzene And 2-Propenenitrile | C18H23NO2 |
| 26300-19-6 | (Z)-2-Butenedioic Acid Polymer With Methoxyethene, Sodium Salt | C7H9NaO5 |
| 26300-51-6 | 2-methyl-2-Propenoic acid methyl ester polymer with butyl 2-propenoate and 2-propenoic acid | (C7H12O2)x.(C5H8O2)x.(C3H4O2)x |
| 26301-10-0 | beta-D-Fructofuranosyl-alpha-D-Glucopyranoside Polymer With Methyloxirane And Oxirane | C17H32O13 |
| 26301-25-7 | 1,3-Isobenzofurandione, Polymer With 2,5-Furandione And Oxybis[Propanol] | C18H20O9 |
| 26301-26-8 | 1,3-Benzenedicarboxylic Acid, Polymer With 2,5-Furandione And 1,2-Propanediol | C15H16O9 |
| 26301-44-0 | Poly (c,i) | |
| 26301-79-1 | D-Mannonic Acid gamma-Lactone | C6H10O6 |
| 26302-39-6 | N-(4-Nitrophenyl)-2-O,3-O,4-O,6-O-Tetraacetyl-beta-D-Glucopyranosylamine | C20H24N2O11 |
| 26303-54-8 | Aluminium Tri(Decanolate) | C30H63AlO3 |
| 26303-63-9 | 4,7,10,13-Tetraoxahexadec-1-Enesulfonic acid Sodium Salt (1:1) | |
| 26303-90-2 | 4-Decenoic acid | C10H18O2 |
| 26304-51-8 | Ethyl 3-methylindole-2-carboxylate | C12H13NO2 |
| 26304-61-0 | Azepindole | C12H14N2 |
| 26305-03-3 | Pepstatin | C34H63N5O9 |
| 26305-13-5 | 5,6-Dimethyl-2,4(1H,3H)-pyrimidinedione | C6H8N2O2 |
| 26305-75-9 | Tris(triphenylphosphine)cobalt chloride | C54H45ClCoP3 |
| 26305-83-9 | [(11-Bromoundecyl)Oxy](Trimethyl)Silane | C14H31BrOSi |
| 26305-91-9 | (3aR,8aalpha,10aalpha)-3a,4a,5,8,8a,9,10,10alpha-Octahydro-4abeta,9alpha-Dimethyl-3-Methylenefuro[2',3':5,6]Cyclohepta[1,2-c]Pyran-2,7(3H,4H)-Dione | C15H20O4 |
| 26305-94-2 | Trimethylsilyl 6-Chlorohexanoate | C9H19ClO2Si |
| 26305-95-3 | Trimethylsilyl 6-Iodohexanoate | C9H19IO2Si |
| 26305-98-6 | Trimethylsilyl 11-Chloroundecanoate | C14H29ClO2Si |
| 26306-02-5 | [(10-Bromodecyl)Oxy]Trimethylsilane | C13H29BrOSi |
| 26306-06-9 | Parecoxib Impurity 15 | C14H13NO |
| 26306-61-6 | 4-(2,4,6-Trichlorophenoxy)Aniline | C12H9Cl4NO |
| 26306-64-9 | 2-(2,4-Dichlorophenoxy)aniline | C12H9Cl2NO |
| 26307-17-5 | 2,5-Dimethyl-3,4-Diphenylcyclopentadienone | C19H16O |
| 26307-50-6 | 4-Bromo-2-(1-methylethyl)phenol | C9H11BrO |
| 26308-28-1 | Ripazepam | C15H16N4O |
| 26308-39-4 | 1-Ethyl-3-Methyl-4-Nitro-1H-Pyrazole-5-Carboxylic Acid | C7H9N3O4 |
| 26308-40-7 / 885319-49-3 | 5-Ethyl-1H-pyrazole-3-carboxylic acid ethyl ester | C8H12N2O2 |
| 26308-41-8 | 3-Ethyl-1-Methyl-4-Nitro-1H-Pyrazole-5-Carboxylic Acid | C7H9N3O4 |
| 26308-42-9 | 3-Ethyl-1-Methyl-1H-Pyrazole-5-Carboxylic acid | C7H10N2O2 |
| 26308-43-0 | 1,3-Diethyl-1H-Pyrazole-5-Carboxylic Acid | C8H12N2O2 |
| 26308-44-1 | 1,3-Diethyl-4-Nitro-1H-Pyrazole-5-Carboxylic Acid | C8H11N3O4 |
| 26308-60-1 | 4-Amino-1-Ethyl-3-Methyl-1H-Pyrazole-5-Carbonitrile | C7H10N4 |
| 26309-83-1 | 1-[(2,4-Dichlorophenyl)Methoxy]-3-(2-Propynyloxy)-2-Propanol Carbamate | C14H15Cl2NO4 |
| 26309-87-5 | 1-(3-Chlorophenoxy)-3-(2-Propynyloxy)-2-Propanol Carbamate | C13H14ClNO4 |
| 26309-95-5 | (Pivaloyloxy)Methyl [2S-[2alpha,5alpha,6beta(S*)]]-6-(2-Amino-2-Phenylacetamido)-3,3-Dimethyl-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate Monohydrochloride | C22H30ClN3O6S |
| 26310-04-3 | 1-[(4-Chlorobenzyl)Oxy]-3-(2-Propynyloxy)-2-Propanol Carbamate | C14H16ClNO4 |
| 26310-11-2 | 1-(4-Bromophenoxy)-3-(2-Propynyloxy)-2-Propanol Carbamate | C13H14BrNO4 |
| 26310-31-6 | cis-5-Methoxy-2-Phenyl-1,3-Dioxane | C11H14O3 |
| 26310-57-6 | trans-5-Methoxy-2-Phenyl-1,3-Dioxane | C11H14O3 |
| 26311-09-1 | N-[5-Amino-2-[(4-Nitrophenyl)Azo]Phenyl]Acetamide | C14H13N5O3 |
| 26311-44-4 | Methyl 4-Pentylbenzoate | C13H18O2 |
| 26311-45-5 | 4-Pentylbenzoic acid | C12H16O2 |